Technology | March 21, 2014

AccessClosure Launches Vascular Closure Device at ACC 2014

AccessClosure Mynx Ace Vascular Closure Device Hemostasis Management Cath Lab

March 21, 2014 — AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical vascular closure product. It is designed to provide patient comfort and uses an easy-to-use deployment system to seal femoral artery access sites. The device helps reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures.

The Mynx Ace uses an extravascular sealant plug for closure. The vendor’s Grip Technology actively adheres to the artery for secure mechanical closure and is completely extravascular. It is made of a bioresorbable material that dissolves within 30 days.

For information: www.accessclosure.com


Related Content

News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
Subscribe Now